Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUROIMPA: Intraarticular Morphine for Chronic Knee Arthritis
NCT02967302Phase 3Unknown
- Start
- Aug 2015
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of morphine in Knee osteoarthritis (3 arms). Primary endpoint: Visual Analogue Scale Pain Intensity at 1 week. Status: unknown.
02
Drugs
morphine
03
Conditions
Knee osteoarthritis
Beyond the preview
Go deeper on NCT02967302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967302.